Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis

To increase the effectiveness of anticancer therapy based on immune checkpoint (IC) inhibition, some ICs are being investigated in addition to those used in clinic. We reviewed data on the relationship between PD-L1, B7-H3, B7-H4, IDO1, Galectin-3 and -9, CEACAM1, CD155, Siglec-15 and ADAM17 express...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansorunov, Danzan, Apanovich, Natalya, Apanovich, Pavel, Kipkeeva, Fatimat, Muzaffarova, Tatyana, Kuzevanova, Anna, Nikulin, Maxim, Malikhova, Olga, Karpukhin, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700640/
https://www.ncbi.nlm.nih.gov/pubmed/34943606
http://dx.doi.org/10.3390/diagnostics11122370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700640/
https://www.ncbi.nlm.nih.gov/pubmed/34943606
http://dx.doi.org/10.3390/diagnostics11122370

Ejemplares similares